[HTML][HTML] Cell therapy: types, regulation, and clinical benefits

AEH El-Kadiry, M Rafei, R Shammaa - Frontiers in Medicine, 2021 - frontiersin.org
Cell therapy practices date back to the 19th century and continue to expand on
investigational and investment grounds. Cell therapy includes stem cell-and non–stem cell …

[HTML][HTML] Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in wound healing

L Mazini, L Rochette, B Admou, S Amal… - International journal of …, 2020 - mdpi.com
Adipose tissue derived stem cells (ADSCs) are mesenchymal stem cells identified within
subcutaneous tissue at the base of the hair follicle (dermal papilla cells), in the dermal …

Stromal vascular fraction technologies and clinical applications

I Andia, N Maffulli, N Burgos-Alonso - Expert opinion on biological …, 2019 - Taylor & Francis
Introduction: The heterogeneous pool of cells found in the stromal vascular fraction of
adipose tissue (SVF) and the purified mesenchymal stromal/stem cells (ASCs) isolated from …

[HTML][HTML] Function and mechanism of mesenchymal stem cells in the healing of diabetic foot wounds

X Yu, P Liu, Z Li, Z Zhang - Frontiers in Endocrinology, 2023 - frontiersin.org
Diabetes has become a global public health problem. Diabetic foot is one of the most severe
complications of diabetes, which often places a heavy economic burden on patients and …

[HTML][HTML] Nano hydrogel-based oxygen-releasing stem cell transplantation system for treating diabetic foot

L Chen, B Zheng, Y Xu, C Sun, W Wu, X Xie… - Journal of …, 2023 - Springer
The employment of stem cells and hydrogel is widespread in contemporary clinical
approaches to treating diabetic foot ulcers. However, the hypoxic conditions in the …

[HTML][HTML] Adipose-derived stem cells for the treatment of diabetic wound: from basic study to clinical application

R Liu, R Dong, M Chang, X Liang… - Frontiers in …, 2022 - frontiersin.org
Diabetic wounds significantly affect the life quality of patients and may cause amputation
and mortality if poorly managed. Recently, a wide range of cell-based methods has emerged …

[HTML][HTML] Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes

A Magenta, MC Florio… - International …, 2021 - spandidos-publications.com
Cell therapy is becoming an attractive alternative for the treatment of patients with no‑option
critical limb ischemia (CLI). The main benefits of cell therapy are the induction of therapeutic …

[HTML][HTML] Autologous peripheral blood mononuclear cells for limb salvage in diabetic foot patients with no-option critical limb ischemia

A Scatena, P Petruzzi, F Maioli, F Lucaroni… - Journal of Clinical …, 2021 - mdpi.com
Peripheral blood mononuclear cells (PBMNCs) are reported to prevent major amputation
and healing in no-option critical limb ischemia (NO-CLI). The aim of this study is to evaluate …

[HTML][HTML] Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications

D Yan, Y Song, B Zhang, G Cao, H Zhou, H Li… - Stem Cell Research & …, 2024 - Springer
Diabetes mellitus (DM) is a serious chronic metabolic disease that can lead to many serious
complications, such as cardiovascular disease, retinopathy, neuropathy, and kidney …

[HTML][HTML] Therapeutic application of adipose-derived stromal vascular fraction in diabetic foot

X Zhao, J Guo, F Zhang, J Zhang, D Liu, W Hu… - Stem Cell Research & …, 2020 - Springer
Diabetic foot is one of the severest complications of diabetes. In severe cases, this disease
may be lead to amputation or even death due to secondary infection and ischemic necrosis …